MWM
KRYS icon

Mindset Wealth Management’s Krystal Biotech KRYS Stock Holding History

Mindset Wealth Management’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$375K Sell
1,450
-343
-19% -$91.3K 0.1% 106
2025
Q4 		$442K Buy
1,793
+323
+22% +$68K 0.12% 97
2025
Q3 		$259K Buy
+1,470
New +$220K 0.07% 139
2025
Q2 		– Sell
-1,450
Closed -$261K – 158
2025
Q1 		$261K Buy
+1,450
New +$244K 0.1% 104

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mindset Wealth Management's KRYS Position: Q1 2026 in Review

Mindset Wealth Management reduced its Krystal Biotech (KRYS) stake by 19% in Q1 2026, selling an estimated $91.3K and leaving 1,450 shares worth $375K. The position accounts for 0.1% of the portfolio, ranked #106.

Mindset Wealth Management first reported a position in KRYS in Q1 2025 and has held it in 4 quarters since. The position peaked at $442K in Q4 2025. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Mindset Wealth Management held 1,450 shares of Krystal Biotech worth $375K as of Q1 2026.
  • Mindset Wealth Management sold 343 Krystal Biotech shares in Q1 2026, an estimated $91.3K.
  • Krystal Biotech made up 0.1% of Mindset Wealth Management's portfolio in Q1 2026, its #106 holding.
  • Mindset Wealth Management first reported a position in Krystal Biotech in Q1 2025 and has held it in 4 quarters since.
  • Mindset Wealth Management's Krystal Biotech position peaked at $442K in Q4 2025.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Mindset Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.